Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study
Crossref DOI link: https://doi.org/10.1186/s40814-015-0031-1
Published Online: 2015-10-23
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Martin, Fabiola
Inoue, Eisuke
Cortese, Irene C. M.
de Almeida Kruschewsky, Ramon
Adonis, Adine
Grassi, Maria Fernanda Rios
Galvão-Castro, Bernardo
Jacobson, Steven
Yamano, Yoshihisa
Taylor, Graham P.
Bland, Martin
License valid from 2015-10-23